Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals

被引:0
|
作者
Quayle, AJ
Coston, WMP
Trocha, AK
Kalams, SA
Mayer, KH
Anderson, DJ
机构
[1] Harvard Univ, Fearing Lab, Brigham & Womens Hosp, Sch Med,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr AIDS Res, Boston, MA 02129 USA
[3] Fenway Community Hlth Ctr, Boston, MA 02115 USA
[4] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA
[5] Brown Univ, AIDS Program, Providence, RI 02903 USA
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 161卷 / 08期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLs play an important role in controlling cell-associated HIV. Since the majority of HIV infections are acquired through sexual transmission, me investigated whether antiviral CTLs were present in the male urogenital tract using semen as a source of T cells. We were able to establish anti-HIV cytolytic lines in five of five HIV-infected men with CD4 counts of >500/mu l, although cloning efficiencies mere lower than with peripheral blood-derived T cells, CTLs generated from the semen of three men mere analyzed in detail and showed a broadly active response, recognizing gag, env, and pol proteins. Detailed analysis of two gag-specific clones from one of the individuals demonstrated HLA class I restriction and recognition of the same p24 epitope (EQASQEVKNWMT). In summary, our results demonstrate the presence of a broad CTL response to HIV in the urogenital tract and provide a rationale for further studies of local enhancement of genital mucosal responses by anti-HIV immunization.
引用
收藏
页码:4406 / 4410
页数:5
相关论文
共 50 条
  • [41] AUTOREACTIVE CYTOTOXICITY IN HIV-INFECTED INDIVIDUALS
    ISRAELBIET, D
    VENET, A
    BELDJORD, K
    ANDRIEU, JM
    EVEN, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 81 (01): : 18 - 24
  • [42] Tuberculous meningitis in HIV-infected individuals
    Vinnard C.
    MacGregor R.R.
    Current HIV/AIDS Reports, 2009, 6 (3) : 139 - 145
  • [43] Late presentation of HIV-infected individuals
    Bottegay, Manuel
    Fluckiger, Ursula
    Hirschel, Bernard
    Furrer, Hansjakob
    ANTIVIRAL THERAPY, 2007, 12 (06) : 841 - 851
  • [44] Immunotherapeutic restoration in HIV-infected individuals
    Kim, June Myung
    Han, Sang Hoon
    IMMUNOTHERAPY, 2011, 3 (02) : 247 - 267
  • [45] Recommendations for immunizations in HIV-infected individuals
    Marquardt, D
    WESTERN JOURNAL OF MEDICINE, 1997, 167 (05): : 343 - 344
  • [46] The use of caspofungin in HIV-infected individuals
    Waters, Laura
    Nelson, Mark
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 899 - 908
  • [47] DETECTION OF CYTOMEGALOVIRUS-SPECIFIC ANTIBODY IN THE CEREBROSPINAL-FLUID OF ASYMPTOMATIC HIV-INFECTED INDIVIDUALS
    STEWART, R
    CHUANG, E
    BERGER, J
    DIX, RD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 764 - 764
  • [48] HEALTHY HIV-INFECTED INDIVIDUALS HARBOR HIV IN THEIR ALVEOLAR MACROPHAGES
    Cribbs, S. K.
    Lennox, J.
    Caliendo, A.
    Brown, L.
    Guidot, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 542 - 542
  • [49] STANDARDIZATION OF INVITRO SYNTHESIS AND DETECTION OF HIV-1-SPECIFIC ANTIBODIES
    INDRACCOLO, S
    ZAMARCHI, R
    VERONESE, ML
    MAZZA, MR
    MION, M
    VERONESI, A
    PANOZZO, M
    COLOMBATTI, M
    BARELLI, A
    ROCCHETTO, P
    AMADORI, A
    CHIECOBIANCHI, L
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) : 105 - 115
  • [50] HIV-1-specific RNA interference
    Boden, D
    Pusch, O
    Ramratnam, B
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (04) : 373 - 380